Cancers have the ability to develop resistance to traditional therapies, and the increasing prevalence of these drug resistant cancers necessitates further research and treatment development. This paper outlines the current knowledge of mechanisms that promote or enable drug resistance, such as drug inactivation, drug target alteration, drug efflux, DNA damage repair, cell death inhibition, and…
Cancers Template
Write in a clean editor, then format for Cancers in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Cancers format
Cancers is a peer-reviewed journal published by MDPI, covering Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis. Over its lifetime it has published 37,000 papers, which have received 806,629 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Cancers 2023, 12, 45–58.
Formats any DOI in Cancers style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Cancer Cells and Metastasis Pancreatic and Hepatic Oncology Research Glioma Diagnosis and Treatment |
| ISSN | 2072-6694 |
| Citation impact (2-yr) | 4.75 |
| h-index | 222 |
| i10-index | 20,356 |
| Article processing charge | $2,598 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | www.mdpi.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Cancers per year
Citation impact of Cancers by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Cancers
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly upregulated in cancers such as in non-small-cell lung cancer, metastatic colorectal cancer, glioblastoma, head and neck cancer, pancreatic cancer, and breast cancer. Various mechanisms mediate the upregulation of EGFR activity, including common mutations and truncations to its extracellular domain, such as…
Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. Its incidence and death rates have increased over the last three decades due to the change in risk factor profiles, better cancer registration, and cancer detection. The number of risk factors of BC is…
Platinum complexes are clinically used as adjuvant therapy of cancers aiming to induce tumor cell death. Depending on cell type and concentration, cisplatin induces cytotoxicity, e.g., by interference with transcription and/or DNA replication mechanisms. Additionally, cisplatin damages tumors via induction of apoptosis, mediated by the activation of various signal transduction pathways, including calcium signaling, death…
During tumor progression, circulating monocytes and macrophages are actively recruited into tumors where they alter the tumor microenvironment to accelerate tumor progression. Macrophages shift their functional phenotypes in response to various microenvironmental signals generated from tumor and stromal cells. Based on their function, macrophages are divided broadly into two categories: classical M1 and alternative M2…